GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Global Wearable Artificial Kidney Market Size and Trends

Global wearable artificial kidney market is estimated to be valued at USD 9.11 Bn in 2024 and is expected to reach USD 22.46 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 13.8% from 2024 to 2031.

To learn more about this report, request sample copy

Conventional dialysis requires patients to remain immobile during treatment, thus, negatively impacting quality of life. Wearable artificial kidneys could allow for portability and mobility, enabling dialysis to be administered at home or anywhere. This flexibility may address issues like long wait times for transplants by providing an alternative treatment option. As technology improves, wearable devices may meet the growing demand for kidney replacement therapies.

Market Driver – Rising Incidences of Kidney Diseases

Due to rising prevalence of chronic diseases such as diabetes and hypertension across both developed and developing nations, there has been rise in the incidences of kidney diseases as well. These chronic diseases are primary causes of end-stage renal diseases (ESRD), commonly known as kidney failure, where the kidneys permanently and severely lose their ability to function. According to estimates, approximately 750,000 patients suffer from ESRD globally, and the numbers are steadily increasing every year. Conventional treatment for ESRD involves costly kidney dialysis or kidney transplant, both of which have significant limitations and risks. While dialysis is a lifelong dependency for patients, transplant options are scarce due to lack of availability of donor kidneys. A wearable artificial kidney can potentially revolutionize the treatment landscape by offering patients an alternative which does not require dialysis or transplants. It would mimic the filtration functions of natural kidneys and allow continuous blood filtration outside of hospital settings. This could help to overcome limitations of current options and improve quality of life of ESRD patients. As the number of underlying reasons increases, there is an increasing demand for a workable therapy substitute. Wearable artificial kidney could witness strong demand in the coming years due to growing prevalence of kidney failure patient pool worldwide.

Kidney dialysis, which is the current standard of care for ESRD patients, poses a huge financial burden on healthcare systems globally. It requires patients to visit dialysis centers thrice every week for hours-long treatment sessions through their lifetime. The average annual cost of dialysis therapy per patient ranges anywhere between US$ 70,000 to US$ 90,000 depending on nation and healthcare system. In the long run, lifetime costs of dialysis add up to massive figures and place unsustainable pressure on payers. A fully functioning wearable artificial kidney offers potential to reduce or eliminate dialysis dependency, and can result in huge cost savings for patients as well as private and public insurers.